Methotrexate

Product NDC: 42291-594
11-digit product format: 422910594
Labeler code: 42291
Product ID: 42291-594_9c5e2f29-a0f1-e9f0-e053-2995a90abf53
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Methotrexate
Dosage form: TABLET
Route: ORAL
Labeler: AvKARE, Inc.
Application: ANDA081099
Marketing category: ANDA
Marketing start: 2014-11-20
Marketing end: 0000-00-00
Substance: METHOTREXATE SODIUM
Active strength: 3 mg/1
Pharmacologic classes: Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
42291-594-01	EA - Each	42291-594	71378ec3-bc56-4bee-99f1-962f554ebc0a	1	2015-01-05

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
3IG1E710ZN	METHOTREXATE SODIUM	7413-34-5	METHOTREXATE SODIUM
YL5FZ2Y5U1	METHOTREXATE	59-05-2	Methotrexate

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
42291-594-01	42291059401	100 TABLET in 1 BOTTLE (42291-594-01)	100 tablet	2014-11-20	0000-00-00	No	No	Current